Skip to content

DT-9081 trial in participants with advanced solid tumours.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516206-28-00
Acronym
DT-9081-CLI-001
Enrollment
84
Registered
2024-09-05
Start date
2022-11-17
Completion date
2025-04-08
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participants with advanced ( unresectable, recurrent or metastatic) solid tumours

Interventions

None listed

Sponsors

Domain Therapeutics
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Belgium, France

Outcome results

None listed

Source: EU CTIS · Data processed: Sep 16, 2026